Enovis Corp ENOV:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/16/24 EDT
52.20quote price arrow down-0.44 (-0.84%)
Volume
324,651
52 week range
43.04 - 66.14
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close52.20
  • 52 Week High66.14
  • 52 Week High Date07/21/23
  • 52 Week Low43.04
  • 52 Week Low Date10/26/23

Key Stats

  • Market Cap2.863B
  • Shares Out54.85M
  • 10 Day Average Volume0.83M
  • Dividend-
  • Dividend Yield-
  • Beta1.78
  • YTD % Change-6.82

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close52.20
  • 52 Week High66.14
  • 52 Week High Date07/21/23
  • 52 Week Low43.04
  • 52 Week Low Date10/26/23
  • Market Cap2.863B
  • Shares Out54.85M
  • 10 Day Average Volume0.83M
  • Dividend-
  • Dividend Yield-
  • Beta1.78
  • YTD % Change-6.82

RATIOS/PROFITABILITY

  • EPS (TTM)-1.89
  • P/E (TTM)-27.60
  • Fwd P/E (NTM)20.12
  • EBITDA (TTM)270.034M
  • ROE (TTM)-3.06%
  • Revenue (TTM)1.817B
  • Gross Margin (TTM)58.12%
  • Net Margin (TTM)-5.66%
  • Debt To Equity (MRQ)40.46%

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Enovis Corp

Profile

MORE
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods...
Matthew Trerotola
Chairman of the Board, Chief Executive Officer
Phillip Berry
Chief Financial Officer, Senior Vice President
Daniel Pryor
Executive Vice President - Strategy and Business Development
Address
2711 CENTERVILLE ROAD, SUITE 400
Wilmington, DE
19808
United States

Top Peers

SYMBOLLASTCHG%CHG
ITGR
Integer Holdings Corp
119.00+1.28+1.09%
IART
Integra Lifesciences Holdings Corp
27.49+1.02+3.85%
MASI
Masimo Corp
120.61+4.46+3.84%
MMSI
Merit Medical Systems Inc
82.26-1.49-1.78%
HAE
Haemonetics Corp
94.80-1.69-1.75%